Trial Profile
A Phase I, Two Centre, Double-Blind, Randomized, Cross-Over Study to Evaluate AZD1386 in Single Doses of 30 mg and 95 mg Compared to Placebo in a Multimodal Experimental Pain Model on Esophageal Sensitivity and Development of Sensitization in Healthy Male Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 May 2011
Price :
$35
*
At a glance
- Drugs AZD 1386 (Primary)
- Indications Visceral pain
- Focus Therapeutic Use
- 10 May 2011 Results presented at the Digestive Disease Week 2011.
- 16 Mar 2011 Results published in the Alimentary Pharmacology and Therapeutics.
- 02 Sep 2009 Actual end date (Jul 2009) added as reported by ClinicalTrials.gov.